产品中心 / 产品类型 / ELISA试剂盒 / ELISA 抗体对

Rabbit anti-Mouse PD-L1/CD274 mAb(CAP) (RM98006)

This standard curve is only for demonstration purposes. A standard curve should be generated for eachassay.

All(1)|
货号: RM98006
促销价:   ¥2100
抗体定制服务咨询 |
商城订购

详细信息

产品名称
Rabbit anti-Mouse PD-L1/CD274 mAb(CAP)
货号
RM98006
免疫原
Recombinant Mouse PD-L1/CD274
纯化方式
Affinity purification
同种型
Rabbit IgG
存储溶液
Supplied as a 0.2um filtered solution in PBS with 0.05%ProClin 300,PH 7.4.
CrossReactivity
/
存储条件
This antibody can be stored at 2℃-8℃ for one monthwithout detectable loss of activity. Antibody products are stable for twelve months fromdate of receipt when stored at -20℃ to -84℃. Preservative:0.05%ProClin 300.Avoid repeated freeze-thaw cycles.

* This package insert must be read in its entirety before using this product.

应用

Mouse PD-L1/CD274 Sandwich ELISA Immunoassay

 Recommended
Concentration
Sample
ELISA Capture1-4ug/mLRabbit anti-Mouse PD-L1/CD274(CAP)(Cat. No.RM98006)
ELISA Detection0.25-1ug/mLRabbit anti- Mouse PD-L1/CD274 (DET)(Cat. No.RM98007)
Standard15.62-1000pg/mLRecombinant Mouse PD-L1/CD274(Cat. No.RP01158)

背景信息

Plays a critical role in induction and maintenance of immune tolerance to self (PubMed:11238124).As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response (PubMed:11238124).Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (PubMed:11015443, PubMed:12719480).3 PublicationsThe PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival (PubMed:12218188, PubMed:27281199).The interaction with PDCD1/PD-1 inhibits cytotoxic T lymphocytes (CTLs) effector function (PubMed:12218188).The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy (PubMed:12218188).2 Publications

>